Bentley Pharmaceuticals (BNT) Q1 2026 Earnings

Screener

Reported May 14, 2026 · Before market open

EPS$0.07

Next report

Aug 13, 2026 (In 1 week)

Versus estimates

Revenue

Q4 2025$3.1B Q3 2025$3.1B Q2 2025$3.0B Q1 2025$2.4B Q4 2024$6.0B

Diluted EPS

Q1 2026$0.07

Q4 2025$0.06 Q3 2025$0.06 Q2 2025$0.06 Q1 2025$0.09 Q4 2024$0.08

FAQ

When did Bentley Pharmaceuticals report Q1 2026 earnings?: Bentley Pharmaceuticals (BNT) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Bentley Pharmaceuticals's Q1 2026 revenue and EPS?: Bentley Pharmaceuticals reported eps of $0.07 for Q1 2026.
How did Bentley Pharmaceuticals's Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, eps declined 22.2% from $0.09.

Ask the moment Bentley Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk